Press Releases
Bristol-Myers Squibb Announces the Pricing Terms of its Cash...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today the pricing terms of its previously announced cash tender offer for up to $500 million aggregate principal...
Press Releases
Lilly and BioNTech Announce Research Collaboration on Novel Cancer...
INDIANAPOLIS and MAINZ, Germany, May 11, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and BioNTech AG today announced they have entered into a research...
Press Releases
Bristol-Myers Squibb to Take Part in Deutsche Bank Global...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Deutsche Bank Global Health Care Conference on Wednesday, May 6, 2015, in Boston. Giovanni...
Press Releases
Eli Lilly and Company Reveals Plan for Innovation Center...
INDIANAPOLIS, May 6, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced plans to establish a new drug delivery and device innovation center in...
Press Releases
Bristol-Myers Squibb to Present at Bank of America Merrill...
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, in...
Press Releases
Lilly Declares Second-Quarter 2015 Dividend
INDIANAPOLIS, May 4, 2015 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter...
Press Releases
U.S. Food and Drug Administration Accepts Supplemental Biologics License...
Application includes CheckMate -066, a clinical trial of Opdivo vs. dacarbazine chemotherapy in patients who had not received prior therapy. CheckMate -066...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.